Cargando…

The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis

Background: Mild cognitive impairment (MCI) is the early phase of Alzheimer's disease (AD). The aim of early intervention for MCI is to decrease the rate of conversion from MCI to AD. However, the efficacy of multiple interventions in MCI, and the optimal methods of delivery, remain controversi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Xin, Wen, Hao, Li, Yu, Lu, Liming, Tang, Chunzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289916/
https://www.ncbi.nlm.nih.gov/pubmed/32581760
http://dx.doi.org/10.3389/fnagi.2020.00121
_version_ 1783545558736044032
author Lai, Xin
Wen, Hao
Li, Yu
Lu, Liming
Tang, Chunzhi
author_facet Lai, Xin
Wen, Hao
Li, Yu
Lu, Liming
Tang, Chunzhi
author_sort Lai, Xin
collection PubMed
description Background: Mild cognitive impairment (MCI) is the early phase of Alzheimer's disease (AD). The aim of early intervention for MCI is to decrease the rate of conversion from MCI to AD. However, the efficacy of multiple interventions in MCI, and the optimal methods of delivery, remain controversial. We aimed to compare and rank the treatment methods for MCI in AD, in order to find an optimal intervention for MCI and a way to prevent or delay the occurrence of AD. Methods: Pair-wise and network meta-analysis were conducted to integrate the treatment effectiveness through direct and indirect evidence. Four English databases and three Chinese databases were searched for international registers of eligible published, single or double blind, randomized controlled trials up to September 31st 2019. We included nine comparative interventions: pharmacological therapies which incorporated cholinesterase inhibitors (ChEI), ginkgo, nimodipine, and Chinese medicine; non-pharmacological therapies comprising of acupuncture, music therapy, exercise therapy, and nutrition therapy; and a placebo group. The primary outcome was the Mini-Mental State Examination (MMSE) score. The secondary outcome was the AD Assessment Scale-cognitive subscale (ADAS-cog). Results: Twenty-eight trials were eligible, including 6,863 participants. In the direct meta-analysis, as for the Mini-Mental State Examination scale, the ChEIs (MD: −0.38; 95% CI: −0.74, −0.01), Chinese medicine (MD: −0.31; 95% CI: −0.75, 0.13), exercise therapy (MD: −0.50; 95% CI: −0.65, −0.35), music therapy (MD: −1.71; 95% CI: −4.49, 1.07), were statistically more efficient than placebo. For AD Assessment Scalecognitive subscale outcome, ChEIs (MD: 1.20; 95% CI: 0.73, 1.68), Acupuncture (MD: 1.36; 95% CI: 1.28, 1.44), Chinese medicine (MD: 0.61; 95% CI: 0.49, 0.73) and exercise (MD: 0.61; 95% CI: 0.49, 0.73) were better than placebo. In the network meta-analysis, the MMSE outcome ranked music therapy (59%) as the best and Acupuncture (26%) as second. Nutrition and Ginkgo treatment had the lowest rank among all interventions. For ADAS-cog outcome, acupuncture (52) ranked the best. Conclusion: Among the nine treatments studied, music therapy appears to be the best treatment for MCI, followed by acupuncture. Our study provides new insights into potential clinical treatments for MCI due to AD, and may aid the development of guidelines for MCI in AD.
format Online
Article
Text
id pubmed-7289916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72899162020-06-23 The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis Lai, Xin Wen, Hao Li, Yu Lu, Liming Tang, Chunzhi Front Aging Neurosci Neuroscience Background: Mild cognitive impairment (MCI) is the early phase of Alzheimer's disease (AD). The aim of early intervention for MCI is to decrease the rate of conversion from MCI to AD. However, the efficacy of multiple interventions in MCI, and the optimal methods of delivery, remain controversial. We aimed to compare and rank the treatment methods for MCI in AD, in order to find an optimal intervention for MCI and a way to prevent or delay the occurrence of AD. Methods: Pair-wise and network meta-analysis were conducted to integrate the treatment effectiveness through direct and indirect evidence. Four English databases and three Chinese databases were searched for international registers of eligible published, single or double blind, randomized controlled trials up to September 31st 2019. We included nine comparative interventions: pharmacological therapies which incorporated cholinesterase inhibitors (ChEI), ginkgo, nimodipine, and Chinese medicine; non-pharmacological therapies comprising of acupuncture, music therapy, exercise therapy, and nutrition therapy; and a placebo group. The primary outcome was the Mini-Mental State Examination (MMSE) score. The secondary outcome was the AD Assessment Scale-cognitive subscale (ADAS-cog). Results: Twenty-eight trials were eligible, including 6,863 participants. In the direct meta-analysis, as for the Mini-Mental State Examination scale, the ChEIs (MD: −0.38; 95% CI: −0.74, −0.01), Chinese medicine (MD: −0.31; 95% CI: −0.75, 0.13), exercise therapy (MD: −0.50; 95% CI: −0.65, −0.35), music therapy (MD: −1.71; 95% CI: −4.49, 1.07), were statistically more efficient than placebo. For AD Assessment Scalecognitive subscale outcome, ChEIs (MD: 1.20; 95% CI: 0.73, 1.68), Acupuncture (MD: 1.36; 95% CI: 1.28, 1.44), Chinese medicine (MD: 0.61; 95% CI: 0.49, 0.73) and exercise (MD: 0.61; 95% CI: 0.49, 0.73) were better than placebo. In the network meta-analysis, the MMSE outcome ranked music therapy (59%) as the best and Acupuncture (26%) as second. Nutrition and Ginkgo treatment had the lowest rank among all interventions. For ADAS-cog outcome, acupuncture (52) ranked the best. Conclusion: Among the nine treatments studied, music therapy appears to be the best treatment for MCI, followed by acupuncture. Our study provides new insights into potential clinical treatments for MCI due to AD, and may aid the development of guidelines for MCI in AD. Frontiers Media S.A. 2020-06-05 /pmc/articles/PMC7289916/ /pubmed/32581760 http://dx.doi.org/10.3389/fnagi.2020.00121 Text en Copyright © 2020 Lai, Wen, Li, Lu and Tang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Lai, Xin
Wen, Hao
Li, Yu
Lu, Liming
Tang, Chunzhi
The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
title The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
title_full The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
title_fullStr The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
title_full_unstemmed The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
title_short The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
title_sort comparative efficacy of multiple interventions for mild cognitive impairment in alzheimer's disease: a bayesian network meta-analysis
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289916/
https://www.ncbi.nlm.nih.gov/pubmed/32581760
http://dx.doi.org/10.3389/fnagi.2020.00121
work_keys_str_mv AT laixin thecomparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT wenhao thecomparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT liyu thecomparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT luliming thecomparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT tangchunzhi thecomparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT laixin comparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT wenhao comparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT liyu comparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT luliming comparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis
AT tangchunzhi comparativeefficacyofmultipleinterventionsformildcognitiveimpairmentinalzheimersdiseaseabayesiannetworkmetaanalysis